Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter, Randomized, Open Label, Parallel Study to Evaluate and Compare the Efficacy and Safety of FK506MR vs Prograf® in Stable Liver Transplantation Patients and a Pharmacokinetics Study

NCT00619398 is registered in ClinicalTrials.gov with Astellas Pharma Inc as lead sponsor.

NCT NCT00619398
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00619398 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter, Randomized, Open Label, Parallel Study to Evaluate and Compare the Efficacy and Safety of FK506MR vs Prograf® in Stable Liver Transplantation Patients and a Pharmacokinetics Study
Lead sponsor
Astellas Pharma Inc
Phase
Phase 3
Overall status
Completed
Start date
January 31, 2008
Completion date
March 31, 2009
Enrollment
172 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

liver transplantation